Avio's Transatlantic Bet: High-Risk Transformation Toward US-Focused Defense Propulsion
Avio S.p.A. (Avio) is a leading European aerospace company specializing in space propulsion. The company's operations are structured around two primary segments: Space Launchers and Solid Propulsion. In its Space Launchers division, Avio serves as the prime contractor for the Vega light-lift launcher family and is a key propulsion subcontractor for the Ariane 6 heavy-lift launcher, for which it produces the P120C solid rocket motors (SRMs). The Solid Propulsion segment focuses on the development and production of SRMs for tactical missile systems.
This analysis, conducted in November 2025, finds Avio at a critical and transformative inflection point. The company is executing a fundamental strategic pivot, evolving from its legacy as a European institutional launch provider into a transatlantic defense propulsion specialist. This transformation is underpinned by three recent, interconnected developments that render any analysis based purely on trailing historical data obsolete.
First, the company's core launch business is in a full production ramp-up. Following the successful return-to-flight of the Vega C rocket in 2024 and the maiden flight of Ariane 6 , 2025 has been a year of consolidating launch cadence and driving revenue growth.
Second, Avio has initiated a transformative 10-year strategic plan aimed at a 2035 target of over €1.2 billion in revenue. This growth is predicated on a significant mix-shift towards defense (projected to be 60% of 2035 revenue) and a massive expansion into the U.S. market (targeted at 35-40% of 2035 revenue). This ambitious strategy was substantially de-risked on November 10, 2025, with the announcement of a term sheet with Lockheed Martin and a Memorandum of Understanding (MoU) with Raytheon (RTX) to support this U.S. expansion.
Third, this strategic pivot is now fully funded. On October 23, 2025, Avio's shareholders approved a €400 million capital increase (rights issue). This transaction fundamentally resets the company's capital structure, creating a pro-forma net cash position of approximately €447 million. However, it also introduces significant, 72% dilution to the share count, a factor that must be central to any valuation.
The investment case for Avio is therefore a long-term, "show-me" story. The market is being asked to fund a 3-5 year "J-curve" of high capital expenditure and guided-flat profitability in exchange for participation in a high-growth, high-margin transatlantic defense business post-2028.
Avio's current and future value is driven by the interplay between its maturing core launch business and its nascent, high-growth defense strategy.
Avio's historical identity is defined by its role as the design authority and prime contractor for the Vega launcher family , Europe's solution for launching small satellites into Low Earth Orbit (LEO).
De-Risking and Ramp-Up: 2024 was a pivotal year, marking the successful return-to-flight of the upgraded Vega C launcher. 2025 has been focused on "consolidating" this success, with multiple launches successfully completed. This operational success is the primary driver of the strong revenue growth seen in 2025, with revenues up 30% in the first half of the year.
New Commercial Model: A significant strategic shift occurred as Avio took over the commercialization and launch service provider (LSP) responsibilities for the Vega family directly, a role previously held by Arianespace. This change provides Avio with a larger share of the total launch revenue and more direct control over its manifest, as evidenced by new contracts being signed directly with customers.
Future Growth (Vega E): Avio is actively developing the next-generation Vega E, funded by the European Space Agency (ESA). This new vehicle will feature the M10 liquid oxygen/methane (methalox) upper stage engine , a critical technological evolution necessary to maintain competitiveness.
Avio is a critical subcontractor for Europe's new Ariane 6 heavy-lift launcher, for which it manufactures the P120C solid rocket motors (SRMs). After a successful maiden flight in 2024 and a first commercial flight in Q1 2025 , the Ariane 6 program is now operational. Arianespace, the launch operator, is targeting an aggressive ramp-up to six or eight launches in 2026. This provides a strong, predictable demand signal for Avio's P120C production line.
The P120C motor is the central industrial link between Avio's two main launcher programs. It is designed to be used as both the first stage of the Vega C rocket and as the strap-on boosters for the Ariane 6. This industrial symbiosis is a significant competitive advantage, allowing for a shared production line, common development costs, and economies of scale that lower the unit cost for both programs, cementing Avio's role as the lynchpin of European solid propulsion.
This is the core of the new investment thesis. Management has set a long-term strategic target to achieve over €1.2 billion in revenue by 2035. This growth is not from the core launch market; it is predicated on a fundamental shift in revenue mix:
Defense Revenue: Targeted to grow from approximately 20% today to 60% of total 2035 revenue.
U.S. Revenue: Targeted to grow from negligible levels today to 35-40% of total 2035 revenue.
While Avio has a strong, high-margin European defense business (producing motors for programs like Aster and CAMM-ER) , the game-changing initiative is the U.S. expansion. This strategy involves building a new, greenfield manufacturing facility in the U.S. to produce SRMs for American defense programs. This plan is now in motion:
The Financing: The €400 million rights issue approved on October 23, 2025, is the explicit funding mechanism for this U.S. expansion.
The Validation: On November 10, 2025, Avio announced it had signed a term sheet with Lockheed Martin and an MoU with Raytheon (RTX) , validating its entry into the U.S. defense industrial base with two of the world's largest primes.
The timeline is critical. Management noted on its Q3 2025 earnings call that work for U.S. customers could begin in its Italian facilities before the U.S. plant is completed (circa 2028). The announcements with Lockheed and Raytheon just weeks later suggest these contracts are not a distant 2030s-era hope, but an imminent source of revenue, significantly de-risking the new strategy.
Avio's competitive position is built on its entrenched status and deep technical expertise. As the prime contractor for Vega, Avio's role is sanctioned and funded by ESA, making it a strategic national asset for Italy and a critical component of Europe's autonomous access to space. Furthermore, its 50+ years of end-to-end expertise in solid, liquid, and cryogenic propulsion is a high-barrier-to-entry capability.
The company is also engaged in defensive R&D to counter the long-term technological threat of reusability, most notably from SpaceX. ESA recently awarded Avio a €40 million contract to develop technologies for a reusable upper stage. This program, which bears a visual resemblance to a "mini-Starship" , is not an offensive commercial strategy. Rather, it is a subsidized R&D initiative that keeps Avio at the technological table and serves a political necessity for ESA, allowing Avio to hedge against long-term technological obsolescence while it executes its primary, and far more lucrative, pivot into the expendable U.S. defense market.
The recent rights issue fundamentally resets Avio's balance sheet and share count, making a pro-forma analysis essential for any coherent valuation.
2024 was the "turnaround" year, marked by the successful Vega C return-to-flight.
Source: FY 2024 Annual Report & Press Release.
Net Revenues: €441.6 million (+30.3% vs. 2023).
Adjusted EBITDA: €31.3 million (+11.6% vs. 2023).
Net Income: €6.4 million (-3.6% vs. 2023).
Net Cash Position (YE 2024): €90.1 million.
Order Backlog (YE 2024): €1.724 billion.
This period reflects the consolidation of the production ramp-up.
Source: 9M 2025 Financial Report & Press Release.
Net Revenues: €351.0 million (+26.3% vs. 9M 2024).
Adjusted EBITDA: €16.4 million (+25.3% vs. 9M 2024). This was achieved despite being partially offset by increased energy costs.
Net Income: €0.5 million (improving from a €2.2M loss in 9M 2024).
Net Financial Position (as of Sep 30, 2025): €47.2 million (cash). This is the pre-raise baseline.
Order Backlog (as of Sep 30, 2025): A new record of €1.86 billion , providing ~4x annual revenue coverage.
The company has confirmed its 2025 guidance.
Net Revenues: €450 – €480 million.
Reported EBITDA: €27 – €33 million.
Net Income: €7 – €10 million.
To value Avio as of November 2025, one must analyze it on a pro-forma basis, reflecting the completion of the €400 million rights issue.
Pro-Forma Share Count: The share count prior to the new rights issue was 27,159,346. The rights issue filing details an offer of a maximum of 19,630,197 new shares. This brings the pro-forma fully-diluted share count to 46,789,543.
Pro-Forma Net Cash: The baseline net cash position as of Q3 2025 was €47.2 million. Assuming the full €400 million rights issue is completed , the pro-forma net cash position is approximately €447.2 million.
The following table summarizes this fundamental reset:
| Metric | Value (Pre-Raise) | Transaction | Value (Pro-Forma) | Source(s) |
| Shares Outstanding | 27,159,346 | +19,630,197 (Rights Issue) | 46,789,543 | |
| Net Financial Position (Cash) | €47.2M (as of Q3 2025) | +€400M (Rights Issue) | ~€447.2M |
Based on this pro-forma structure, the current valuation is stretched, indicating the market is pricing in future growth, not current earnings.
Current Share Price (Nov 11, 2025): ~€32.85.
Pro-Forma Market Capitalization: 46.79M shares * €32.85 = €1.537 billion.
Pro-Forma Enterprise Value (EV): €1.537B (Market Cap) - €447.2M (Pro-Forma Net Cash) = €1.09 billion.
Using the mid-point of 2025 revenue guidance (€465M) and the high-end of adjusted EBITDA guidance (€36M) , the pro-forma multiples are:
Pro-Forma 2025E EV/Revenue: €1.09B / €465M = 2.34x. This is in line with the LTM peer multiple of 2.3x.
Pro-Forma 2025E EV/Adj. EBITDA: €1.09B / €36M = 30.3x. This is exceptionally high, more than double the aerospace & defense peer average of ~15x.
Pro-Forma 2025E P/E: €1.537B / €8.5M (mid-point NI) = 180.8x. This multiple is astronomical compared to the European A&D industry average of ~33x.
This "great disconnect" in valuation confirms the market is not valuing Avio on its 2025 earnings. The current price is a "call option" on the 2035 strategic plan. This confusion is reflected in three distinct recent prices for the stock:
The "Floor" Price: €20.37, the subscription price for the rights issue, set at a deep discount to ensure success.
The "Institutional" Price: ~€37.75, the price at which institutional investors bought a 9.4% block of shares from Avio's largest shareholder, Leonardo, in October.
The "Market" Price: ~€32.85, the volatile trading price as the market digests the dilution.
Leonardo, the most strategic insider, executed a savvy maneuver: it sold high at €37.75 and used the proceeds to subscribe low at €20.37, monetizing part of its stake while retaining its strategic 19.3% holding.
Avio is facing an extraordinarily high-risk period, simultaneously managing three mission-critical programs, creating a "triple ramp" with no room for error:
Vega C Launch Ramp: Ramping the cadence of a launcher that only returned to flight in 2024. A single failure would ground the fleet, halt a primary revenue stream, and destroy market confidence.
Ariane 6 Production Ramp: Meeting the aggressive 2026 launch schedule for Ariane 6 requires a flawless P120C motor production ramp.
U.S. Plant Build: Executing a €400 million greenfield capital expenditure program in a foreign market to serve new, demanding defense customers.
A failure or significant delay in any one of these three areas would almost certainly cascade, starving the other programs of capital, resources, and management attention.
Avio's competitive "moat" is under deliberate assault, primarily from its own main customer.
The "Challengers": ESA is intentionally fostering competition to lower European launch costs through its "European Launcher Challenge". This program has pre-selected five microlauncher companies (Isar Aerospace, Rocket Factory Augsburg, Maiaspace, PLD Space, and Orbex) to compete for future ESA contracts.
The Long-Term Threat: Reusable launchers, dominated by SpaceX, make Avio's core expendable SRM-based model a legacy technology.
The U.S. defense pivot is therefore not just a growth strategy; it is a survival strategy. Avio's quasi-monopoly on European institutional small launch will erode by 2030. Management is using its 5-year head start, funded by the €400M, to diversify away from a customer (ESA) that is actively funding its competition, and into the high-margin, protected U.S. defense market.
Avio remains highly dependent on European institutional budgets (ESA, EU), which are stable but subject to complex political cycles. Furthermore, the launch business is one of binary outcomes; launch failure is a paramount risk.
Inflation poses a direct and immediate threat to Avio's profitability. The company is executing a €1.86 billion backlog of long-term contracts (many of which are likely fixed-price) in a high-inflation environment. This is not a theoretical risk. Avio's 2025 financial reports explicitly state that profitability was "partly offset by increased energy costs". Persistent high costs for energy, raw materials, and labor could systematically erode the profitability of Avio's entire backlog, even as revenues grow.
This 5-year forecast is built from a "Year 0" baseline of the company's 2025 full-year guidance. Critically, all "per share" metrics are calculated using the Pro-Forma Share Count of 46.79 million to reflect the dilutive impact of the October 2025 rights issue.
Key Modeling Assumptions (The "J-Curve"):
EBITDA Trough: The model respects management's guidance for flat EBITDA until 2028 during the U.S. ramp-up. This is modeled by layering in significant new U.S. operating expenses (OpEx) for staff and R&D, which leads to margin compression from 2026-2028, even as revenue grows.
CapEx Burn: The model assumes the €400 million in rights issue proceeds is spent on the U.S. plant from 2026-2028. This adds ~€133 million/year in expansionary CapEx on top of a baseline ~€35 million/year (based on 2024 levels ), creating a significant multi-year cash burn.
Terminal Valuation: A 2030 terminal EV/EBITDA multiple is applied. The Base and High cases use 15x (in line with A&D peers ), while the Low case uses 10x (a "failed execution" discount).
Baseline (Year 0 - 2025E):
Source: 2025 Guidance & Pro-Forma Analysis (Section 3).
Revenue: €465M (mid-point).
Adj. EBITDA: €36M (high-end).
Adj. Net Income: €8.5M (mid-point).
Pro-Forma Adj. EPS: €8.5M / 46.79M shares = €0.18.
Pro-Forma Net Cash (YE 2025): ~€447M.
Fundamentals: Core Launch (Vega/Ariane) grows 5% annually. Core Defense (Europe) grows 10%. The U.S. plant is built on-budget from 2026-2028, burning the €400M CapEx. U.S. OpEx of ~€30M/yr is added, depressing margins. U.S. revenue begins modestly in 2028 , ramping to €150M by 2030. The "J-Curve" plays out as guided: EBITDA is flat for 3 years, then inflects.
P&L Forecast (Base Case):
Share Price Trajectory (Base Case):
Fundamentals: Core business is strong. U.S. revenue starts in 2026 from Italian facilities and ramps faster, reaching €300M by 2030. U.S. OpEx is absorbed efficiently. The "J-Curve" is shallower and shorter. EBITDA grows modestly through 2028 and then explodes.
P&L Forecast (High Case):
Share Price Trajectory (High Case):
Fundamentals: A Vega C launch failure or major Ariane 6 delay hits the core business. The U.S. plant build is delayed and suffers cost overruns, burning more than the €400M. U.S. revenue fails to materialize by 2030. The "J-Curve" becomes a "cash incinerator," and the company is forced to raise debt by 2029.
P&L Forecast (Low Case):
Share Price Trajectory (Low Case):
The 5-year scenario analysis suggests the current share price is pricing in a high degree of optimism.
Table: 5-Year Target Price Probability
The probability-weighted 5-year price target of €27.26 is approximately 17% below the current trading price of ~€32.85. This indicates that the market is pricing in a scenario significantly more optimistic than the "Realistic Execution" Base Case and is attributing a low probability to the significant execution risks of the "triple ramp."
RISK-SKEWED VALUATION
Management Alignment: 9/10
Narrative: Alignment is exceptionally high. CEO Giulio Ranzo co-invested alongside 50 other managers via the 'In-Orbit S.p.A.' vehicle, which holds a stake in Avio. More importantly, the 2025 Remuneration Policy was revised to perfectly align incentives with the new strategy by introducing "Order Intake of the US Business" as a new long-term incentive (LTI) KPI. This directly ties management pay to the success of the U.S. pivot.
Revenue Quality: 7/10
Narrative: Quality is high but concentrated. The record order backlog of €1.86 billion provides approximately 4 years of revenue visibility. Contracts are long-term, sticky, and sourced from institutional customers (ESA) and, more recently, top-tier defense primes (Lockheed Martin, Raytheon). The primary risk is the fixed-price nature of some contracts in an inflationary environment.
Market Position: 6/10
Narrative: This is a tale of two markets. In European institutional launch, Avio is the entrenched incumbent but is now facing customer-sponsored competition. In U.S. defense propulsion, it is a new entrant but is entering the market with two of the largest possible partners. The score is balanced, reflecting a "moat" that is simultaneously shrinking (Europe) and expanding (U.S.).
Growth Outlook: 9/10
Narrative: The targeted growth is exceptional, though very long-dated. Management's 2035 plan targets >€1.2B in revenue (a ~10% 10-year CAGR) and a 5x increase in EBITDA. The U.S. defense market pivot is the singular catalyst for this, and the €400M in funding provides the fuel.
Financial Health: 8/10
Narrative: On a pro-forma basis, financial health is excellent. Post-rights-issue, the balance sheet is transformed, moving from €47.2M in net cash to a pro-forma ~€447M net cash position (see Section 3). This capital is sufficient to fully fund the high-CapEx 5-year plan without needing additional debt.
Business Viability: 7/10
Narrative: High. As a strategic asset for European autonomous access to space , Avio benefits from significant "too-big-to-fail" institutional support. The pivot to the U.S. defense market adds a second, independent, and non-correlated pillar of viability, strengthening the long-term case.
Capital Allocation: 5/10
Narrative: This is the central debate. Management is executing a massive, high-risk, high-reward bet, funded by extreme shareholder dilution (a 72% increase in share count). This is either a brilliant, company-making decision or a disastrous overreach. The modest dividend is now secondary.
Market Sentiment: 5/10
Narrative: Highly polarized and volatile. The 52-week range of €9.52 to €65.20 is exceptionally wide. The stock is down ~40% in the last month alone , collapsing from its October high as the market digests the rights issue. It is trading well below its 200-day moving average , reflecting a clear negative technical trend.
Profitability: 3/10
Narrative: Current profitability is razor-thin; 9M 2025 net income was just €0.5M on €351M in revenue. Crucially, management is guiding for this to continue, with flat EBITDA and margin compression through 2028 as part of the "J-Curve" investment.
Track Record: 4/10
Narrative: Poor, but improving. The 2022 Vega C failure was a major blow to credibility and shareholder value. However, the successful RTF in 2024 and the flawless execution of multiple 2025 missions are critical steps in rebuilding trust.
Overall Blended Score: 6.3/10
LONG-TERM TRANSFORMATION
Investment Thesis: Avio is fundamentally misunderstood if valued on any 2025-2027 financial metric. The company is, in effect, a "re-IPO" executing a venture-style pivot. The €400 million rights issue is not a rescue package; it is a strategic "war chest" to transform Avio from a single-customer (ESA), single-region (Europe) institutional supplier into a transatlantic, high-margin defense propulsion specialist, validated by its new partnerships with Lockheed Martin and Raytheon.
The "J-Curve" Is the Story: The investment thesis requires investors to believe in management's 2035 targets. This belief must be strong enough to endure 3-5 years of high cash burn (CapEx for the U.S. plant) and deliberately flat-to-negative earnings (OpEx for U.S. R&D). This is a classic "J-Curve" investment, not a value play.
Valuation & Asymmetry: The current pro-forma valuation (~€33/share) is pricing in significant success, offering little margin of safety for the immense "triple ramp" execution risk. Our 5-year probability-weighted price target of €27.26 (see Section 5) suggests the stock is currently over-extended. The market appears to be under-pricing the probability of the "Low Case" (execution stumble). The valuation is currently skewed, with the risk of a ~93% loss (Low Case: €2.14) versus a ~43% gain (High Case: €47.02) from the current price.
Key Catalysts (Upside):
Faster U.S. Revenue: Confirmation of U.S. defense revenue being recognized in 2026/2027 from Italian facilities.
U.S. Plant Milestones: "Shovel in the ground" and "on-budget" progress reports for the new U.S. facility.
Third U.S. Partner: Announcement of a third major U.S. partner beyond Lockheed and Raytheon.
Key Risks (Downside):
Launch Failure: Any failure of a Vega C rocket would be catastrophic for the core revenue stream and market confidence.
CapEx Burn: Any delay or cost overrun at the U.S. plant, which would "incinerate" the €400M buffer.
Margin Squeeze: Persistent inflation destroying the profitability of the €1.86B fixed-price backlog.
DECADE-LONG BET
As of November 11, 2025, Avio (AVIO.MI) is trading at €32.85. The stock is in a clear and severe short-term downtrend, trading significantly below its 200-day moving average of €41.34. This negative price action is driven by the massive dilutive overhang of the €400 million rights issue. The market is in "price discovery" as it absorbs the 72% increase in share count. The stock is likely to remain weak and highly volatile until the rights issue is fully subscribed and digested.
DILUTION OVERHANG
View Avio S.p.A. (AVIO.MI) stock page
Loading the interactive version of this report…